Abstract
Objectives: To evaluate the relationship between prostate cancer and several potential lifestyle risk factors.
Methods: We analyzed data obtained from a population-based case–control study conducted in eight Canadian provinces. Risk estimates were generated by applying multivariate logistic regression methods to 1623 histologically confirmed prostate cancer cases and 1623 male controls aged 50–74.
Results: Cases were more likely to have a first-degree relative with a history of cancer, particularly prostate cancer (OR = 3.1, 95% CI = 1.8–5.4). Reduced risks of prostate cancer were observed among those of Indian descent (OR = 0.2, 95% CI = 0.1–0.5) or any Asian descent (OR = 0.3, 95% CI = 0.2–0.6) relative to those of western European descent. Total fat consumption, tomato and energy intake, were not associated with prostate cancer. The risk of prostate cancer was inversely related to the number of cigarettes smoked daily (p = 0.06) and cigarette pack-years (p < 0.01), while no association was observed between the total number of smoking years or the number of years since smoking cessation. Anthropometric measures and moderate and strenuous levels of leisure time physical activity were not strongly related to prostate cancer. In contrast, strenuous occupational activities at younger ages appeared protective.
Conclusions: Our analyses are limited by the absence of data related to tumor severity and screening history. Further studies are needed to investigate the relationship between behavioral risk factors and prostate cancer screening practices.
Similar content being viewed by others
References
National Cancer Institute of Canada (1997) Canadian Cancer Statistics 1997. Toronto, Canada: NC1C.
Boyle P, Maissonneuve P, Napalkov P (1995) Geographical and temporal patterns of incidence and mortality from prostate cancer. Urology 46(Suppl. 3A): 47-55.
Dijkman GA, Debruyne FM (1996) Epidemiology of prostate cancer. Eur Urol 30: 281-295.
World Health Organization (1985) International Classification of Diseases, 9th revision. Geneva: WHO.
Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC (1990) Family history and risk of prostate cancer. Prostate 17: 337-347.
Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC (1992) Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 89: 3367-3371.
Block G, Hartman AM, Naughton D (1990) A reduced dietary questionnaire: development and validation. Epidemiology 1: 58-64.
Willett WC (1998) Nutritional Epidemiology, 2nd edn. New York: Oxford University Press, pp. 95-97.
Health and Welfare Canada (1988) Nutrient Value of Some Common Foods. Ottawa: Ministry of Supply and Services Canada.
Setchell KDR, Adlercreutz H (1988) Mammalian lignans and phytoestrogens, recent studies on their formation, metabolism and biological role in health and disease. In: Roland IR, ed. Role of Gut Flora in Toxicity and Cancer. London: Academic Press, pp. 315-345.
SAS release version 6.11. Cary NC: Sas Institute Inc.
Rothman KJ, Greenland S (1998) Modern Epidemiology, 2nd edn. Philadelphia, PA Lippincott-Raven, pp. 256-257.
Carter BS, Carter HB, Isaacs JT (1990) Epidemiology evidence regarding predisposing factors to prostate cancer. Prostate 16: 187-197.
Scott R Jr, Mutchnik DH, Laskowski TZ, Schmalhorst WR (1969) Carcinoma of the prostate in elderly men: incidence, growth characteristics and clinical significance. J Urol 101: 602-607.
Levy I, Gibbons L, Collins JP, Perkins DG, Mao Y (1993) Prostate cancer trends in Canada: rising incidence or increased detection? Can Med Assoc J 149: 617-624.
Lesko SM, Rosenberg L, Shapiro S (1996) Family history and prostate cancer risk. Am J Epidemiol 144: 1041-1047.
Schnatter AR, Acquavella JF, Thompson FS, Donaleski D, Thériault G (1990) An analysis of death ascertainment and follow-up through Statistics Canada's Mortality Data Base system. Can J Public Health 81: 60-65.
Nomura AM, Kolonel LN (1991) Prostate cancer: a current perspective. Epidemiol Rev 13: 200-227.
Shibata A, Whittemore AS (1997) Genetic predisposition to prostate cancer: possible explanations for ethnic differences in risk. Prostate 32: 65-72.
Montie JE, Pienta KJ (1994) Review of the role of androgenic hormones in the epidemiology of benign prostatic hypertrophy and prostate cancer: Urology 43: 892-899.
Dai WS, Gutai JP, Kuller LH, Cauley JA (1988) Cigarette smoking and serum sex hormones in men. Am J Epidemiol 128: 796-805.
Armstrong BG, Kazantzis G (1985) Prostatic cancer and chronic respiratory and renal disease in British cadmium workers: a case control study. Br J Ind Med 42: 540-545.
Pour PM (1983) Prostatic cancer induced in MRC rats by N-nitrosobis (2-oxopropyl)-amine and N-nitrosobis (2-hydroxy-propyl)amine. Carcinogenesis 4: 49-55.
Cerhan JR, Torner JC, Lynch CF, et al. (1997) Association of smoking, body mass and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States). Cancer Causes Control 8: 229-238.
Statistics Canada (1997) National Population Health Survey: supplements. Ottawa: Statistics Canada, Health Statistics Division.
Ghadirian P, Lacroix A, Maisonneuve P, et al. (1996) Nutritional factors and prostate cancer: a case-control study of French Canadians in Montreal, Canada. Cancer Causes Control 7: 428-436.
Breslow RA, Weed DL (1998) Review of epidemiologic studies of alcohol and prostate cancer: 1971–1996. Nutr Cancer 30: 1-13.
Jain MG, Hislop GT, Howe GR, Burch JD, Ghadirian P (1998) Alcohol and other beverage use and prostate cancer risk among Canadian men. Int J Cancer 78: 707-711.
De Stefani E, Fierro L, Barrios E, Ronco A (1995) Tobacco, alcohol, diet and risk of prostate cancer. Tumori 81: 315-320.
Thune I, Lund E (1994) Physical activity and the risk of prostate cancer and testicular cancer: a cohort study of 53,000 Norwegian men. Cancer Causes Control 5: 549-556.
Lee IM (1995) Exercise and physical health: cancer and immune function. Res Q Exerc Sport 66: 286-291.
Dessypris A, Kuoppasalmi K, Adlercreutz H (1976) Plasma cortisol, testosterone, androstenedione, and luteinizing hormone (LH) in a non-competitive marathon run. J Steroid Biochem 7: 33-37.
Morville R, Pesquies PC, Guezennec CY, Serrurier BD, Guignard M (1979) Plasma variations in testicular and adrenal androgens during prolonged physical exercise in man. Ann Endocrinol (Paris) 40: 501-510.
Oremek GM, Seiffert UB (1996) Physical activity releases prostate-specific antigen (PSA) from the prostate gland into blood and increases serum PSA concentrations. Clin Chem 42: 691-695.
Kolonel LN (1996) Nutrition and prostate cancer. Cancer Causes Control 7: 83-94.
Whittemore AS, Kolonel LN, Wu AH, et al. (1999) Prostate cancer in relation to diet, physical activity, and body size in blacks, whites and Asians in the United States and Canada. J Natl Cancer Inst 87: 652-661.
Talamini R, Franceschi S, La Vecchia C, Guarneri S, Negri E (1993) Smoking habits and prostate cancer: a case-control study in northern Italy. Prev Med 22: 400-408.
Kolonel LN, Yoshizawa CN, Hankin JH (1988) Diet and prostatic cancer: a case-control study in Hawaii. Am J Epidemiol 127: 999-1012.
Severson RK, Grove JS, Nomura AMY, Stemmerman GN (1988) Body mass and prostatic cancer: a prospective study. BMJ 297: 713-715.
Andersson SO, Baron J, Bergstrom R, Lindgren C, Wolk A, Adami HO (1996) Lifestyle factors and prostate cancer risk: a case-control study in Sweden. Cancer Epidemiol Biomarkers Prev 5: 509-513.
Adlercreutz H (1990) Western diet and western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 201: 3-23.
Ellison LF, Stokes J, Gibbons L, Lindsay J, Levy I, Morrison H (1998) Monograph Series on aging-related diseases. X: Prostate cancer. Chron Dis Can 19: 1-18.
Giovannucci E, Rimm EB, Colditz GA, et al. (1993) A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 85: 1571-1579.
Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA (1998) Vegetable and fruit consumption and prostate cancer risk: a cohort study in the Netherlands. Cancer Epidemiol Biomarkers Prev 7: 673-680.
Clinton SK, Emenhiser C, Schwartz SJ, et al. (1996) Cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 5: 823-833.
DiMascio P, Kaiser S, Sies H (1989) Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274: 532-538.
Mills PK, Beeson WL, Phillips RL, Fraser GE (1989) Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 64: 598-604.
Schuman LM, Mandel JS, Radke A, Seal U, Halberg F (1982) Some selected features of the epidemiology of prostatic cancer. Minneapolis-St. Paul, Minnesota case-control study, 1976–1979. In: Magnus K, ed. Trends in Cancer Incidence: causes and practical implications. Washington, DC: Hemisphere, pp. 345-354.
Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC (1995) Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 87: 1767-1776.
Hsing AW, Comstock GW, Abbey H, Polk BF (1990) Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst 82: 941-946.
Nomura AM, Stemmerman GN, Lee J, Craft NE (1997) Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev 6: 487-491.
Weisburger JH (1998) Evaluation of the evidence on the role of tomato products in disease prevention. Proc Soc Exp Biol Med 218: 140-143.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Villeneuve, P.J., Johnson, K.C., Kreiger, N. et al. Risk factors for prostate cancer: results from the Canadian National Enhanced Cancer Surveillance System. Cancer Causes Control 10, 355–367 (1999). https://doi.org/10.1023/A:1008958103865
Issue Date:
DOI: https://doi.org/10.1023/A:1008958103865